Journey Medical (DERM) Treasury Shares (2020 - 2026)

Journey Medical has reported Treasury Shares for 7 years, with the latest figure at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 25.34% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 25.34% YoY), and the FY2025 full-year result was $1.8 million, down 21.02% from the prior year.
• Treasury Shares for Q1 2026 stood at $1.7 million, down from $1.8 million in the prior quarter.
• The five-year high for Treasury Shares was $2.7 million in Q2 2024, with the low at $1.3 million in Q4 2023.
• Historically, Treasury Shares has averaged $2.0 million across 5 years, with a median of $1.9 million in 2023.
• Annual changes were most pronounced in 2022 — Treasury Shares soared 238.96% — and 2023, when it slumped 43.13%.
• Journey Medical's Treasury Shares stood at $2.3 million in 2022, then tumbled by 42.2% to $1.3 million in 2023, then jumped by 79.04% to $2.3 million in 2024, then declined by 21.02% to $1.8 million in 2025, then declined by 7.91% to $1.7 million in 2026.
• The last three Treasury Shares figures came in at $1.7 million (Q1 2026), $1.8 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.